1 |
Sheehan J, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors. J Neurosurg (Suppl) 2005;102:247-54.
DOI
|
2 |
Cohen MH, Matthew MJ. Small cell bronchogenic carcinoma: A distinct clinicopathologic entity. Semin Oncol 1978;5(3):234-8.
|
3 |
Katyal S, Oliver J Ш, Peterson MS, Ferris JV, Carr BS, Baron RL. Extrahepatic metastases of hepatocellular carcinoma. Radiology 2000; 216:698-703.
DOI
ScienceOn
|
4 |
Choi JH, Yoo HS, Son CG, Cho CK. Regression of small cell lung carcinoma by herbal medicine: A case with an 8-year follow-up. J Korean Oriental Oncol 2005;10(1):87-9.
|
5 |
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 1982;5:649-55.
DOI
|
6 |
Uka K, Aikata H, Takaki S, Shirakawa H, Jeong SC, Yamashina K, et al. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol 2007;13:414-20.
DOI
|
7 |
Jeong TY, Park BK, Lee YW, Cho CK, Yoo HS. Prospective analysis on survival outcomes of nonsmall cell lung cancer stages over IIIb treated with HangAm-Dan. Chin J Lung Cancer 2010;13(11):1009-15.
|
8 |
Park BK, Yoo HS, Lee YW, Han SW, Cho JH, Son CG, et al. Retrospective cohort analysis for lung cancer patients treated with Wheel Balance Therapy (WBT). J Korean Orient Int Med 2007;28(3):531-43.
|
9 |
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-47.
DOI
|
10 |
Lee DE, Lee SY, Kim JS, Cho CK, Yoo HS , Choi SJ. Antitumor effect of HangAm-Dan (HAD) and its ingredients on Calu6 and MCF-7 human cancer cell lines. J Korean Oriental Med 2009;30(5):50-60.
|
11 |
Yoo HS, Kim SH, Lee YH, Cho CK, Lee KH. Two cases of endometrial cancer treated with palliative herbal medication Hangam-dan (HAD). J Korean Oriental Med 2007;28(4):176-80.
|
12 |
Oh YS, Oh MS, Son CG, Cho CK, Song TY. The effects of PSM on immune response. J Korean Oriental Med 2001;22(1):46-52.
|
13 |
Shin JW, Son JY, OH SM, Han SH, Wang JH, Cho JH, et al. An herbal formula, CGX, exerts hepatotherapeutic effects on dimethylnitrosamine-induced chronic liver injury model in rats. World J Gastroenterol 2006;12(38):6142-8.
DOI
|
14 |
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
DOI
|
15 |
Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, et al. Changing epidemiology of small cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 2006;24:4539-44.
DOI
|
16 |
Jackman DM, Johnson BE. Small cell lung cancer. Lancet 2005;366:1385-96.
DOI
|
17 |
Patel AM, Dunn WF, Trastek VF. Staging systems of lung cancer. Mayo Clin Proc 1993;68 :475-82.
DOI
|
18 |
Honeybourne D. Lung metastases from a primary hepatocellular carcinoma. Thorax. 1980;35:316-37.
DOI
|
19 |
Kato Y, Ferguson TB, Bennett DE, Burford TH. Oat cell carcinoma of the lung: a review of 138 cases. Cancer 1969;23:517-24.
DOI
|